Application 020943

Type
NDA
Sponsor
RECRO GAINESVILLE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001VERELAN PMVERAPAMIL HYDROCHLORIDECAPSULE, EXTENDED RELEASE;ORAL100MGYesNo
002VERELAN PMVERAPAMIL HYDROCHLORIDECAPSULE, EXTENDED RELEASE;ORAL200MGYesNo
003VERELAN PMVERAPAMIL HYDROCHLORIDECAPSULE, EXTENDED RELEASE;ORAL300MGYesYes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N020943-001VERELAN PMVERAPAMIL HYDROCHLORIDE100MGCAPSULE, EXTENDED RELEASE / ORALRLD1998-11-25
N020943-002VERELAN PMVERAPAMIL HYDROCHLORIDE200MGCAPSULE, EXTENDED RELEASE / ORALRLD1998-11-25
N020943-003VERELAN PMVERAPAMIL HYDROCHLORIDE300MGCAPSULE, EXTENDED RELEASE / ORALRLD, RS1998-11-25

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02N020943-001VERELAN PM100MGCAPSULE, EXTENDED RELEASE / ORALRLD1998-11-25011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020943-002VERELAN PM200MGCAPSULE, EXTENDED RELEASE / ORALRLD1998-11-25011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020943-003VERELAN PM300MGCAPSULE, EXTENDED RELEASE / ORALRLD, RS1998-11-25011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020943-001VERELAN PM100MGCAPSULE, EXTENDED RELEASE / ORALRLD1998-11-2531067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020943-002VERELAN PM200MGCAPSULE, EXTENDED RELEASE / ORALRLD1998-11-2531067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020943-003VERELAN PM300MGCAPSULE, EXTENDED RELEASE / ORALRLD, RS1998-11-2531067a03dcf5…
2025-08-23 18:47 UTC2025-08N020943-001VERELAN PM100MGCAPSULE, EXTENDED RELEASE / ORALRLD1998-11-256a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020943-002VERELAN PM200MGCAPSULE, EXTENDED RELEASE / ORALRLD1998-11-256a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020943-003VERELAN PM300MGCAPSULE, EXTENDED RELEASE / ORALRLD, RS1998-11-256a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020943-001VERELAN PM100MGCAPSULE, EXTENDED RELEASE / ORALRLD1998-11-25fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020943-002VERELAN PM200MGCAPSULE, EXTENDED RELEASE / ORALRLD1998-11-25fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020943-003VERELAN PM300MGCAPSULE, EXTENDED RELEASE / ORALRLD, RS1998-11-25fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020943-001VERELAN PM100MGCAPSULE, EXTENDED RELEASE / ORALRLD1998-11-25b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020943-002VERELAN PM200MGCAPSULE, EXTENDED RELEASE / ORALRLD1998-11-25b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020943-003VERELAN PM300MGCAPSULE, EXTENDED RELEASE / ORALRLD, RS1998-11-25b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020943-001VERELAN PM100MGCAPSULE, EXTENDED RELEASE / ORALRLD1998-11-2503ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020943-002VERELAN PM200MGCAPSULE, EXTENDED RELEASE / ORALRLD1998-11-2503ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020943-003VERELAN PM300MGCAPSULE, EXTENDED RELEASE / ORALRLD, RS1998-11-2503ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020943-001VERELAN PM100MGCAPSULE, EXTENDED RELEASE / ORALRLD1998-11-252680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020943-002VERELAN PM200MGCAPSULE, EXTENDED RELEASE / ORALRLD1998-11-252680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020943-003VERELAN PM300MGCAPSULE, EXTENDED RELEASE / ORALRLD, RS1998-11-252680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020943-001VERELAN PM100MGCAPSULE, EXTENDED RELEASE / ORALRLD1998-11-255bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020943-002VERELAN PM200MGCAPSULE, EXTENDED RELEASE / ORALRLD1998-11-255bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020943-003VERELAN PM300MGCAPSULE, EXTENDED RELEASE / ORALRLD, RS1998-11-255bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020943-001VERELAN PM100MGCAPSULE, EXTENDED RELEASE / ORALRLD1998-11-25d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020943-002VERELAN PM200MGCAPSULE, EXTENDED RELEASE / ORALRLD1998-11-25d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020943-003VERELAN PM300MGCAPSULE, EXTENDED RELEASE / ORALRLD, RS1998-11-25d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N020943-001VERELAN PM100MGCAPSULE, EXTENDED RELEASE / ORALRLD1998-11-25d06236e962d9…
2024-10-29 15:01 UTC2024-10N020943-002VERELAN PM200MGCAPSULE, EXTENDED RELEASE / ORALRLD1998-11-25d06236e962d9…
2024-10-29 15:01 UTC2024-10N020943-003VERELAN PM300MGCAPSULE, EXTENDED RELEASE / ORALRLD, RS1998-11-25d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020943-001VERELAN PM100MGCAPSULE, EXTENDED RELEASE / ORALRLD1998-11-2579d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020943-002VERELAN PM200MGCAPSULE, EXTENDED RELEASE / ORALRLD1998-11-2579d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020943-003VERELAN PM300MGCAPSULE, EXTENDED RELEASE / ORALRLD, RS1998-11-2579d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N020943-001VERELAN PM100MGCAPSULE, EXTENDED RELEASE / ORALRLD1998-11-25301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N020943-002VERELAN PM200MGCAPSULE, EXTENDED RELEASE / ORALRLD1998-11-25301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N020943-003VERELAN PM300MGCAPSULE, EXTENDED RELEASE / ORALRLD, RS1998-11-25301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N020943-001VERELAN PM100MGCAPSULE, EXTENDED RELEASE / ORALRLD1998-11-251e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N020943-002VERELAN PM200MGCAPSULE, EXTENDED RELEASE / ORALRLD1998-11-251e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N020943-003VERELAN PM300MGCAPSULE, EXTENDED RELEASE / ORALRLD, RS1998-11-251e350fbaab3a…
2024-05-31 18:47 UTC2024-05N020943-001VERELAN PM100MGCAPSULE, EXTENDED RELEASE / ORALRLD1998-11-258072bd15b7f6…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2019-12-13 00:20 UTC2019-12N020943-001AB174a2ff9319b5…
2019-12-13 00:20 UTC2019-12N020943-002AB174a2ff9319b5…
2019-09-15 20:21 UTC2019-09N020943-001AB1b00525d2431f…
2019-09-15 20:21 UTC2019-09N020943-002AB1b00525d2431f…
2019-07-19 19:46 UTC2019-07N020943-001AB1ea99ee380514…
2019-07-19 19:46 UTC2019-07N020943-002AB1ea99ee380514…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Verapamil HydrochlorideVERAPAMIL HYDROCHLORIDEChartwell RX, LLC18f6d349-8c5c-4443-ac65-16bf6619ecdc2025-03-25Warnings, Adverse reactionsExact identifier
application applno (NDA): 020943
application number: NDA020943
Verapamil HydrochlorideVERAPAMIL HYDROCHLORIDEWilshire Pharmaceuticals, Inc.5f665d08-e1e4-422a-88c2-d8834abf9e1a2024-11-27Warnings, Adverse reactionsExact identifier
application applno (NDA): 020943
application number: NDA020943

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 33 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
62175-485Verapamil HydrochlorideVerapamil HydrochlorideLannett Company, Inc.NDACurrent
62175-485Verapamil HydrochlorideVerapamil HydrochlorideLannett Company, Inc.NDACurrent
62175-485Verapamil HydrochlorideVerapamil HydrochlorideLannett Company, Inc.NDACurrent
62175-485Verapamil HydrochlorideVerapamil HydrochlorideLannett Company, Inc.NDACurrent
62175-485Verapamil HydrochlorideVerapamil HydrochlorideKremers Urban Pharmaceuticals Inc.NDACurrent
62175-486Verapamil HydrochlorideVerapamil HydrochlorideLannett Company, Inc.NDACurrent
62175-486Verapamil HydrochlorideVerapamil HydrochlorideLannett Company, Inc.NDACurrent
62175-486Verapamil HydrochlorideVerapamil HydrochlorideLannett Company, Inc.NDACurrent
62175-486Verapamil HydrochlorideVerapamil HydrochlorideLannett Company, Inc.NDACurrent
62175-486Verapamil HydrochlorideVerapamil HydrochlorideKremers Urban Pharmaceuticals Inc.NDACurrent
62175-487Verapamil HydrochlorideVerapamil HydrochlorideLannett Company, Inc.NDACurrent
62175-487Verapamil HydrochlorideVerapamil HydrochlorideLannett Company, Inc.NDACurrent
62175-487Verapamil HydrochlorideVerapamil HydrochlorideLannett Company, Inc.NDACurrent
62175-487Verapamil HydrochlorideVerapamil HydrochlorideLannett Company, Inc.NDACurrent
62175-487Verapamil HydrochlorideVerapamil HydrochlorideKremers Urban Pharmaceuticals Inc.NDACurrent
62175-570VERELAN PMverapamil hydrochlorideLannett Company, Inc.NDACurrent
62175-570VERELAN PMverapamil hydrochlorideKremers Urban Pharmaceuticals Inc.NDACurrent
62175-570VERELAN PMverapamil hydrochlorideLannett Company, Inc.NDACurrent
62175-570VERELAN PMverapamil hydrochlorideLannett Company, Inc.NDACurrent
62175-570VERELAN PMverapamil hydrochlorideLannett Company, Inc.NDACurrent
62175-571VERELAN PMverapamil hydrochlorideLannett Company, Inc.NDACurrent
62175-571VERELAN PMverapamil hydrochlorideKremers Urban Pharmaceuticals Inc.NDACurrent
62175-571VERELAN PMverapamil hydrochlorideLannett Company, Inc.NDACurrent
62175-571VERELAN PMverapamil hydrochlorideLannett Company, Inc.NDACurrent
62175-571VERELAN PMverapamil hydrochlorideLannett Company, Inc.NDACurrent
62175-572VERELAN PMverapamil hydrochlorideLannett Company, Inc.NDACurrent
62175-572VERELAN PMverapamil hydrochlorideKremers Urban Pharmaceuticals Inc.NDACurrent
62175-572VERELAN PMverapamil hydrochlorideLannett Company, Inc.NDACurrent
62175-572VERELAN PMverapamil hydrochlorideLannett Company, Inc.NDACurrent
62175-572VERELAN PMverapamil hydrochlorideLannett Company, Inc.NDACurrent
63629-7233Verapamil HydrochlorideVerapamil HydrochlorideBryant Ranch PrepackNDACurrent
63629-7233Verapamil HydrochlorideVerapamil HydrochlorideBryant Ranch PrepackNDACurrent
63629-8017Verapamil HydrochlorideVerapamil HydrochlorideBryant Ranch PrepackNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
60230SUPPL2019-10-04
60225SUPPL2019-10-04
45916SUPPL2016-11-22
45938SUPPL2016-11-21
35690SUPPL2014-10-15
3817SUPPL2014-10-14
26264SUPPL2011-11-16
13792SUPPL2011-11-14
35688SUPPL2010-04-30
3815SUPPL2010-04-09
26263SUPPL2010-04-05
35689SUPPL2010-04-04
26262SUPPL2009-12-24
13791SUPPL2009-12-17
3816SUPPL2007-05-07
26261SUPPL2004-05-07
13790SUPPL2004-05-07
35687ORIG1998-11-25
26260ORIG1998-11-25
21294ORIG1998-11-25